'Spermbots' Could Help Women Trying to Conceive (includes video)
By Phys.org,
Phys.org
| 01. 13. 2016
Sperm that don't swim well rank high among the main causes of infertility. To give these cells a boost, women trying to conceive can turn to artificial insemination or other assisted reproduction techniques, but success can be elusive. In an attempt to improve these odds, scientists have developed motorized "spermbots" that can deliver poor swimmers—that are otherwise healthy—to an egg. Their report appears in ACS' journal Nano Letters.
Artificial insemination is a relatively inexpensive and simple technique that involves introducing sperm to a woman's uterus with a medical instrument. Overall, the success rate is on average under 30 percent, according to the Human Fertilisation & Embryology Authority of the United Kingdom. In vitro fertilization can be more effective, but it's a complicated and expensive process. It requires removing eggs from a woman's ovaries with a needle, fertilizing them outside the body and then transferring the embryos to her uterus or a surrogate's a few days later.
Each step comes with a risk for failure. Mariana Medina-Sánchez, Lukas Schwarz, Oliver G. Schmidt and colleagues from the Institute for Integrative...
Related Articles
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Angus Liu, Fierce Pharma | 06.16.2025
A second patient has died following treatment with Sarepta Therapeutics’ Elevidys, raising more doubts about the Duchenne muscular dystrophy (DMD) gene therapy’s safety profile.
Sarepta and its ex-U.S. partner Roche reported the death early Sunday. Like the first case, disclosed...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...